InSphero and Path BioAnalytics Announce Partnership to Develop Advanced 3D Airway Tissue Model for Cystic Fibrosis Research
19. Dezember 2018 03:59 ET
|
InSphero AG
Schlieren, Switzerland, Dec. 19, 2018 (GLOBE NEWSWIRE) -- InSphero AG and Path BioAnalytics today announced a partnership through which Path BioAnalytics will produce and test 3D cystic fibrosis...
AstraZeneca Relies on 3D InSight™ Human Islet Microtissues in Pancreatic Beta-cell Study
29. November 2018 08:00 ET
|
InSphero AG
Schlieren, Switzerland, Nov. 29, 2018 (GLOBE NEWSWIRE) -- In a recent study published in ScienceAdvances, researchers in the Innovative Medicines and Early Development (IMED) Biotech Unit of...
InSphero achieves new milestone with Akura™ Flow organ-on-a-chip technology in low-clearance drug study
11. Oktober 2018 00:37 ET
|
InSphero AG
Schlieren, Switzerland, Oct. 11, 2018 (GLOBE NEWSWIRE) -- InSphero AG today announced that it has successfully completed a collaborative project with the FHNW University in Switzerland to develop a...
InSphero Receives Additional USD 10m for Organ-on-a-Chip Disease Models
13. Juni 2018 02:00 ET
|
InSphero AG
Schlieren, Switzerland, June 13, 2018 (GLOBE NEWSWIRE) -- InSphero AG today announced that it has raised USD 10 million in its latest funding round with additional financing, secured from internal...
InSphero Partners with ALPCO to Advance Diabetes Research
11. Juni 2018 09:00 ET
|
InSphero AG
Schlieren, Switzerland, June 11, 2018 (GLOBE NEWSWIRE) -- InSphero AG, the leading provider of 3D cell-based platforms for preclinical drug safety and efficacy testing, today announced that it is...
InSphero and Charles River Announce PDX Partnership
26. Oktober 2017 08:00 ET
|
InSphero AG
Schlieren, Switzerland, Oct. 26, 2017 (GLOBE NEWSWIRE) -- InSphero AG and Charles River Laboratories International, Inc. today announced a partnership through which Charles River will license its...
InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC
18. Oktober 2017 08:00 ET
|
InSphero AG
Schlieren, Switzerland, Oct. 18, 2017 (GLOBE NEWSWIRE) -- InSphero AG, the leading supplier of assay-ready 3D cell culture models for accelerating drug discovery and development, will present data...
Comprehensive Study by AstraZeneca and Genentech Confirms Superiority of InSphero Human Liver Microtissues for Prediction of Drug-Induced Liver Injury
29. Juni 2017 08:00 ET
|
InSphero AG
Schlieren, Switzerland, June 29, 2017 (GLOBE NEWSWIRE) -- In the most comprehensive evaluation of 3D spheroid hepatic cultures conducted to date, a publication co-authored by lead toxicologists and...